|
Friday, May 12, 2023 |
||
|
Preliminary programme |
||
| 09:30-15:00 | Registration | |
|
5 |
NUCLEAR MEDICINE IN METABOLIC DISEASES (EANM, IAEA GUIDELINES) The session is partially supported by Pfizer |
|
|
Chairpersons: |
||
| 10:00-10:15 | Arsen Ristić, Belgrade | Heart amyloidosis |
| 10:15-10:30 | Dragana Šobić Šaranović, Belgrade |
Detection of heart amyloidosis with nuclear medicine methods |
| 10:30-10:45 | Leposava Brajković, Belgrade | Detection of brain amyloid deposition with nuclear medicine methods |
| 10:45-11:00 |
Discussion |
|
|
6 |
NUCLEAR MEDICINE ADVANCES IN TECHNOLOGY (EANM, IAEA GUIDELINES) |
|
| 11:00-11:10 | Marko Grahovac, Vienna |
Potential application of artificial intelligence in neuroendocrine tumors |
| 11:10-11:20 | Uroš Miljković, Vienna | Acromegaly: Hypophysis – MRI Imaging and Pitfalls |
| 11:20-11:30 | Mach Georg, Vienna | Imaging of pancreas: look into unknown |
| 11:30-11:40 | Vojislav Antić, Belgrade | Advantages of CZT SPECT/CT camera in detection of neuroendocrine tumors |
| 11:40-11:50 | Snežana Golubović, Belgrade | Standardization and harmonization of TSH measurement |
| 11:50-12:00 | Branislava Ilinčić, Novi Sad | Clinical genetics in nuclear medicine, possibilities and visions |
| 12:00-12:15 | Discussion | |
| 12:30 | Farewell refreshment | |